Does hepatic insulin resistance impair insulin’s suppression of liver glucose production?

Hepatic insulin resistance is a well-established contributor to dysregulated glucose control: the liver continues releasing glucose despite insulin concentrations that would normally restrain production.

Clinical and physiologic evidence

• Tracer-based hyperinsulinemic–euglycemic clamp studies directly show that insulin suppresses endogenous (largely hepatic) glucose production, and that this suppression is weaker in fatty liver and type 2 diabetes.
• In type 2 diabetes, inadequately suppressed hepatic glucose output contributes to both fasting and post-meal hyperglycemia. The defect is generally relative rather than absolute: glucose production may decrease with high insulin exposure but remain inappropriately elevated at usual circulating insulin levels.
• In a small within-person type 2 diabetes study, insulin-mediated suppression of glucose production was only 29% when fasting glucose was elevated. Following approximately 8 kg weight loss, suppression increased to 93%, fasting glucose normalized, and liver fat fell. This is consistent with restoration of hepatic insulin responsiveness, although the study cannot isolate the respective effects of weight loss, reduced liver fat, and improved peripheral insulin sensitivity.

Mechanistic and metabolic context

• Hepatic steatosis is associated with reduced insulin-mediated suppression of liver glucose production in clamp studies, supporting fatty liver as an important metabolic correlate of hepatic insulin resistance.
• Adiposity also predicts weaker suppression of endogenous glucose production. In a stable-isotope, two-stage clamp cohort spanning ages 19–78 years, adiposity—not age alone—was associated with poorer hepatic insulin responsiveness.
• Hepatic glucose overproduction is one contributor to hyperglycemia, alongside impaired muscle glucose uptake, inadequate insulin secretion, medications, and other metabolic factors.

Bottom line

• The claim is strongly supported: hepatic insulin resistance impairs insulin’s ability to suppress liver glucose production, leaving glucose output inappropriately high and thereby contributing meaningfully to hyperglycemia.